(-0.88%) 5 071.01 points
(-0.98%) 38 010 points
(-1.08%) 15 810 points
(-1.09%) $81.73
(-2.76%) $1.974
(-2.33%) $2 302.70
(-3.69%) $26.64
(-1.62%) $945.90
(0.43%) $0.936
(0.95%) $11.09
(0.47%) $0.800
(0.15%) $93.44
1.50% SEK 8.10
Live Chart Being Loaded With Signals
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions...
Stats | |
---|---|
Dzisiejszy wolumen | 40 641.00 |
Średni wolumen | 55 023.00 |
Kapitalizacja rynkowa | 95.22M |
EPS | SEK0 ( 2024-04-25 ) |
Następna data zysków | ( SEK0 ) 2024-07-12 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -1.480 |
ATR14 | SEK0.107 (1.32%) |
Iconovo AB (publ) Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Iconovo AB (publ) Finanse
Annual | 2023 |
Przychody: | SEK7.08M |
Zysk brutto: | SEK-53.81M (-760.22 %) |
EPS: | SEK-4.39 |
FY | 2023 |
Przychody: | SEK7.08M |
Zysk brutto: | SEK-53.81M (-760.22 %) |
EPS: | SEK-4.39 |
FY | 2022 |
Przychody: | SEK17.12M |
Zysk brutto: | SEK17.24M (100.75 %) |
EPS: | SEK-5.69 |
FY | 2021 |
Przychody: | SEK15.41M |
Zysk brutto: | SEK21.31M (138.27 %) |
EPS: | SEK-0.832 |
Financial Reports:
No articles found.
Iconovo AB (publ)
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an agreement with Immune System Regulation AB for the development of an inhaled covid-19 vaccine in Iconovo's inhaler ICOone; and Respiratorius AB (publ) to develop inhalation product to treat COPD. Iconovo AB (publ) was founded in 2013 and is based in Lund, Sweden.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej